Mutations or abnormalities in the BRCA1 (BReast CAncer Gene 1) and BRCA2 genes are the most common cause of hereditary breast cancer. In the Indian population, there is a higher proportion of BRCA1- associated breast cancer (66%) than BRCA2 (45%). Men with a BRCA mutation, especially BRCA2 are also at a higher risk of Breast Cancer (6-8%).
Dr. Aparna Rajadhyaksha, Medical Consultant, Metropolis Healthcare contributes an insightful article to The New Indian Express explaining the significance of Breast Cancer Gene Testing and its impact on treatment.
To read the online version, click here: https://www.newindianexpress.com/cities/kochi/2022/jul/05/breast-cancer-genetic-testing-impact-and-advantages-2472883.html#BRCA1 #BRCA2 #BreastCancer #OvarianCancer #LungCancer #Genetesting #ProstateCancer #Genomexpert #Oncomet #ScientificExcellence #MetropolisInnovationCell #MolecularOncology #BRCA1 #BRCA2 #BreastCancer #OvarianCancer #LungCancer #Genetesting #ProstateCancer #Genomexpert #Oncomet #ScientificExcellence #MetropolisInnovationCell #MolecularOncology
Posted On: 26 Jul 2022 10:03 AM
